Matt Kaeberlein, PhD
CEO, Optispan
Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc., an Affiliate Professor at the University of Washington, and Co-Founder the Dog Aging Project. He is deeply committed to advancing human and animal health by targeting the biological processes underlying aging and age-related disease. A distinguished leader in his field, Dr. Kaeberlein is a Fellow of the American Association for the Advancement of Science, the American Aging Association, and the Gerontological Society of America. He has published over 250 scientific papers on longevity. In addition to receiving the 2020 Robert W. Kleemeier Award from the Gerontological Society of America, Dr. Kaeberlein has been honored with numerous awards from leading organizations, including the Ellison Medical Foundation, Alzheimer’s Association, American Federation for Aging Research, Glenn Foundation, Murdock Trust, and the United States National Institutes of Health and National Institute on Aging. Dr. Kaeberlein is the founding Director of the University of Washington Healthy Aging and Longevity Research Institute and the Biological Mechanisms of Healthy Aging Training Program. He has served as Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, President and Chair of the American Aging Association, Chair of the Gerontological Society of America Biological Sciences Section, and on the Board of Directors for the Federation of American Societies for Experimental Biology and the Alliance for Longevity Initiatives.